Registry of biomedical companies:
[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 564 active entries
Blaesiring 7
Basel, CH-4057, Switzerland
Switzerland Phone: +4161- 6924461
Description:
Jain PharmaBiotech was formed to conduct research, provide consulting services, and publish strategic reports for the pharmaceutical and biotechnology industries. Consultations performed include a variety of assignments from various companies, which include technology assessment, competitive intelligence, market analysis, design of clinical trials and finding innovative solutions for problems. Activities O Research and documentation of various technologies: genomics, proteomics, molecular diagnostics, nanobiotechnology, RNA interference, and drug delivery.
O Integration of biotechnologies for development of personalized medicine
O Research in gene therapy of brain tumors:preclinical investigation of destruction of glioblastoma multiforme by genetically modified bacteria.
O Planning and protocols of clinical trials of drugs for neurological disorders.
O Publication of reports on biotechnology, which are constantly updated. Current topics include: -Alzheimers disease: new Drugs, markets, and companies, 2018
-Animal Biotechnology: technologies, markets & companies, 2018 -Antiviral Therapeutics: technologies, markets & companies, 2018 -Biochips: technologies, markets & companies, 2018-Biomarkers: technologies, markets and companies, 2018 -Cardiovascular Drug Delivery, 2018 -Cell therapy: technologies, markets and companies, 2018 -Cytogenetics: technologies, markets and companies, 2018 -DNA Sequencing, 2016 -Drug Delivery in Cancer:technologies,markets & companies, 2018 -Drug Delivery in Disorders of the Central Nervous System, 2018 -Gene therapy: technologies, markets & companies, 2018 -Molecular diagnostics: technologies, markets &companies, 2018 -Nanobiotechnology: applications, markets and companies, 2018 -Neuroprotection: drugs, markets & companies, 2018 -Nitric Oxide: therapeutics, markets & companies, 2018 -Pain Therapeutics: drugs, markets & companies, 2018 -Personalized Medicine: scientific & commercial aspects, 2018 -Proteomics: technologies, markets &companies, 2018 -RNAi: technologies, markets &companies, 2018 -Transdermal Drug Delivery, 2018 -Therapeutic Drug Monitoring, 2018 O Authoring and editing of textbooks. Currents books are: -Jain KK. Handbook of Nanomedicine, Humana/Springer, 3rd ed, 2017. -Jain KK (ed). Drug Delivery Systems, Humana/Springer, 2008. -Jain KK. Textbook of Hyperbaric Medicine, Springer, 6th ed 2017. -Jain KK. Textbook of Personalized Medicine, Springer, 2nd ed, 2015. -Jain KK (ed). Drug Delivery in Central Nervous System, Springer, 2010. -Jain KK. Handbook of Biomarkers, Springer, 2010. -Jain KK. Handbook of Neuroprotection, Springer, 2009. -Jain KK. Applications of Biotechnology in Cardiovascular Therapeutics. Springer, 2011. -Jain KK. Drug-induced Neurological Disorders, 3rd ed. Hogrefe AG, 2012. -Jain KK (ed) Nanooncology. Clinics Lab Med, Elsevier, 2012. -Jain KK. Handbook of Nanomedicine, 2nd ed, Humana/Springer, 2012. -Jain KK. Applications of Biotechnology in Neurology, Springer 2013. -Jain KK. Applications of Biotechnology in Oncology, Springer 2014 -Jain KK (ed). Drug Delivery Systems, 2nd ed, Humana/Springer, 2014. -Jain KK (ed). Applied Neurogenomics. Humana/Springer, January 2015. -Jain KK. Textbook of Personalized Medicine, 2nd ed, Springer, 2015. -Jain KK. Handbook of Nanomedicine, 3rd ed, Springer, 2017. -Jain KK. Handbook of Biomarkers, Springer, 2nd ed, 2017. -Jain KK. Handbook of Neuroprotection, Springer, 2nd ed, 2018 (in preparation) Web site: : http://www.pharmabiotech.ch Contact: Prof. Dr. med. K. K. Jain
Selected Categories:
Last update of this entry: August 14, 2018
|